HKSE · 8357.HK
Republic Healthcare Limited
HK$0.21+HK$0.01 (+5.5%)
Republic Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 24.64% below the high.
Loading market information…
HKSE · 8372.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 23, 2026, 05:56 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Grand Brilliance Group Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 7.78% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Grand Brilliance Group Holdings Limited’s forward annual dividend is HK$0.00 per share, paid annual. The forward yield is 1.51% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Grand Brilliance Group Holdings Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Grand Brilliance Group Holdings Limited, an investment holding entity, primarily operates by distributing medical equipment and related items across Hong Kong. Its extensive product portfolio encompasses various medical supplies, including disposables, specialized instruments, and advanced medical machinery. The company also undertakes the development of innovative healthcare products. Beyond product distribution, it delivers comprehensive medical device solutions such as in-depth market trend assessments, strategic sourcing, post-sale support, technical training, equipment rental, and stringent quality assurance. Additionally, the firm manages maintenance services and holds several registered trademarks. Its diverse client base spans both public and private healthcare facilities, independent clinics, charitable groups, academic institutions, and direct consumers. Established in 1997, the company is headquartered in Tsuen Wan, Hong Kong, and operates as a subsidiary of B&A Success Limited.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:51 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
HK$0.21+HK$0.01 (+5.5%)
Republic Healthcare Limited’s quoted price sits in the upper half of its reported 52-week range, 24.64% below the high.
HK$0.11+HK$0.01 (+7.92%)
Wanjia Group Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 47.85% below the high.
HK$0.19-HK$0.02 (-10.38%)
Kelfred Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 65.45% below the high.
HK$0.11-HK$0.01 (-5.88%)
Raily Aesthetic Medicine International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 42.86% below the high.
HK$0.15-HK$0.00 (-0.65%)
Medicskin Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 24.0% below the high.
HK$0.07-HK$0.00 (-1.35%)
China Healthwise Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
HK$0.32HK$0.00 (0.0%)
Qianhai Health Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 77.5% below the high.
HK$0.06-HK$0.00 (-1.61%)
Elegance Optical International Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 64.12% below the high.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
